Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants

被引：0
|
作者：
Valerie Pestinger
Matthew Smith
Toju Sillo
John M. Findlay
Jean-Francois Laes
Gerald Martin
Gary Middleton
Phillipe Taniere
Andrew D. Beggs
机构：
[1] University of Birmingham,Surgical Research Laboratory, Institute of Cancer and Genomic Sciences
[2] Queen Elizabeth Hospital Birmingham,Institute of Immunology and Immunotherapy
[3] Northern Devon Healthcare NHS Trust,undefined
[4] OncoDNA,undefined
[5] PierianDx,undefined
[6] University of Birmingham,undefined
来源：
Molecular Diagnosis & Therapy | 2020年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：339 / 349
页数：10
相关论文
共 31 条
  • [31] Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer-Related Single-Nucleotide Variants and Copy Number Variants Using Simulated Cell-Free DNA
    Yang, Xin
    Chu, Yuxing
    Zhang, Rui
    Han, Yanxi
    Zhang, Lucheng
    Fu, Yu
    Li, Dan
    Peng, Rongxue
    Li, Dongdong
    Ding, Jiansheng
    Li, Ziyang
    Zhao, Meiru
    Zhang, Kuo
    Lu, Tian
    Yi, Lang
    Wu, Qisheng
    Lin, Guigao
    Xie, Jiehong
    Liu, Tao
    Yang, Ling
    Yi, Xin
    Li, Jinming
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (04): : 525 - 536
1234